May 7, 2019
TG Therapeutics (NASDAQ:TGTX) has announced presentation of long-term follow-up data of its Phase 2 open label extension trial of ubiltuximab...
February 28, 2019
March was dubbed Multiple Scleorsis Awareness Month in 2015 by New Jersey Governor Chris Christie. Here's what investors should know.
November 25, 2018
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
April 11, 2018
A company getting approval to list to the NASDAQ means a more international reach for Canadian companies listing on the...
April 9, 2018
CBD is improving health and driving the cannabis industry. Know more about its health benefits and opportunities for CBD-based companies.
March 14, 2018
March has been a busy month for Biogen with its voluntary withdrawal of Zinbryta and its acquisition of Pfizer's PF-04958242.
March 1, 2018
Biocure Technology Inc. (formerly Gravis Energy Corp.) (CSE: CURE) (the"Company" or "Biocure") is pleased to announce that effective of today's...